% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • sunlow sunlow Jun 10, 1998 2:37 PM Flag


    Would approval of the Nir stent give an immediate
    upward move to BSX stock price? The news from the
    Company is that they expect approval any day at the
    latest mid July. Just curious what others think would
    happen the moment the news comes out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Probably will have a short term sell off as in
      "buy the rumor, sell the news". I think it is very
      risky for BSX to have pegged mid July as the Nir
      approval date. Given the vagaries of bureaucrats and
      bureacracies the fact is, if for whatever reason Nir is
      delayed beyond that point, the stock may be punished.

      • 1 Reply to Stock_Detective
      • If NIR is half as good as they claim, it should
        help shore them up
        in the stent market but that's
        all. There has been too much pre-game hype for 1 new
        product. A company as big as BSX would not risk all their
        eggs in one basket. As far as FDA approval, they have
        been in the industry long enough to know when to make
        announcements with any degree of confidence. They have
        historically been investor friendly. Let's hope they don't
        botch this one.

23.97+0.20(+0.84%)Aug 26 4:01 PMEDT